All products / DC11357
Tolazamide
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $250 USDRequest a quote / confirm availability → |
| 250 mg | $500 USDRequest a quote / confirm availability → |
| 1 g | $1,000 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
Tolazamide is a first generation sulfonylurea that inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel (KIR6.2; IC50 = 4.2 µM in HEK293 cells transfected with the human receptor).It has no effect on glucose uptake in L6 rat skeletal muscle cells when used at a concentration of 0.6 mg/mL but enhances glucose uptake two-fold when used in combination with insulin.In vivo, tolazamide (128 mg/kg) reduces glomerulosclerosis and albumin excretion in a rat model of insulin-dependent diabetes induced by streptozotocin.Formulations containing tolazamide have been used in the treatment of type 2 diabetes.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC11357 |
|---|---|
| Product name | Tolazamide |
| CAS | 1156-19-0 |
| Molecular formula | C14H21N3O3S |
| Molecular weight | 311.4 |
| Purity | >98% |
| SMILES | Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Tolazamide (DC11357)